[go: up one dir, main page]

WO2008022060A3 - composés organiques et leurs utilisations - Google Patents

composés organiques et leurs utilisations Download PDF

Info

Publication number
WO2008022060A3
WO2008022060A3 PCT/US2007/075771 US2007075771W WO2008022060A3 WO 2008022060 A3 WO2008022060 A3 WO 2008022060A3 US 2007075771 W US2007075771 W US 2007075771W WO 2008022060 A3 WO2008022060 A3 WO 2008022060A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein kinase
kinase activity
imidazo
pyridine derivatives
modulating protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/075771
Other languages
English (en)
Other versions
WO2008022060A2 (fr
Inventor
Christopher Thomas Brain
Kim Sunkyu
David L Farley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH Austria
Novartis AG
Original Assignee
Novartis Pharma GmbH Austria
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma GmbH Austria, Novartis AG filed Critical Novartis Pharma GmbH Austria
Publication of WO2008022060A2 publication Critical patent/WO2008022060A2/fr
Publication of WO2008022060A3 publication Critical patent/WO2008022060A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a pour objet des composés organiques utilisés pour le traitement, la prévention et/ou l'amélioration de maladies.
PCT/US2007/075771 2006-08-14 2007-08-13 composés organiques et leurs utilisations Ceased WO2008022060A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82226706P 2006-08-14 2006-08-14
US60/822,267 2006-08-14

Publications (2)

Publication Number Publication Date
WO2008022060A2 WO2008022060A2 (fr) 2008-02-21
WO2008022060A3 true WO2008022060A3 (fr) 2008-12-31

Family

ID=39083015

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/075771 Ceased WO2008022060A2 (fr) 2006-08-14 2007-08-13 composés organiques et leurs utilisations

Country Status (1)

Country Link
WO (1) WO2008022060A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445515B2 (en) 2008-12-22 2013-05-21 Chemocentryx, Inc. C5aR antagonists
US9126939B2 (en) 2010-06-24 2015-09-08 Pingchen Fan C5AR antagonists
US9745268B2 (en) 2014-09-29 2017-08-29 Chemocentryx, Inc. Processes and intermediates in the preparation of C5aR antagonists
US11285138B2 (en) 2016-01-14 2022-03-29 Chemocentryx, Inc. Method of treating C3 glomerulopathy

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110494433B (zh) 2017-03-22 2023-03-17 廖细斌 布鲁顿酪氨酸激酶抑制剂
CA3133096A1 (fr) * 2019-03-15 2020-09-24 Alterity Therapeutics Limited Composes et methodes de traitement de maladies
WO2024092222A1 (fr) * 2022-10-28 2024-05-02 Escient Pharmaceuticals, Inc. Modulateurs du récepteur d de protéine g liée à mas, produits et procédés associés

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019828A2 (fr) * 1999-09-17 2001-03-22 Basf Aktiengesellschaft Inhibiteurs de kinase utilises comme agents therapeutiques
WO2004058755A2 (fr) * 2002-12-24 2004-07-15 Biofocus Plc Bibliotheques de composes
WO2004058264A1 (fr) * 2002-12-24 2004-07-15 Biofocus Plc Bibliotheques de composes de derives 2h-spiro(isoquinoline-1,4-piperidine) et composes associes pour des composes de ciblage pouvant se lier au recepteur de la proteine g
WO2005021545A1 (fr) * 2003-09-03 2005-03-10 Galapagos Nv Derives d'imidazo[1,5-a]pyridine ou d'imidazo[1,5-a]piperidine et leur utilisation dans la preparation d'un medicament dirige contre les troubles lies au recepteur 5-ht2a
WO2005037836A2 (fr) * 2003-10-15 2005-04-28 Osi Pharmaceuticals, Inc. Imidazopyrazines utilisees comme inhibiteurs de la tyrosine kinase

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019828A2 (fr) * 1999-09-17 2001-03-22 Basf Aktiengesellschaft Inhibiteurs de kinase utilises comme agents therapeutiques
WO2004058755A2 (fr) * 2002-12-24 2004-07-15 Biofocus Plc Bibliotheques de composes
WO2004058264A1 (fr) * 2002-12-24 2004-07-15 Biofocus Plc Bibliotheques de composes de derives 2h-spiro(isoquinoline-1,4-piperidine) et composes associes pour des composes de ciblage pouvant se lier au recepteur de la proteine g
WO2005021545A1 (fr) * 2003-09-03 2005-03-10 Galapagos Nv Derives d'imidazo[1,5-a]pyridine ou d'imidazo[1,5-a]piperidine et leur utilisation dans la preparation d'un medicament dirige contre les troubles lies au recepteur 5-ht2a
WO2005037836A2 (fr) * 2003-10-15 2005-04-28 Osi Pharmaceuticals, Inc. Imidazopyrazines utilisees comme inhibiteurs de la tyrosine kinase

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445515B2 (en) 2008-12-22 2013-05-21 Chemocentryx, Inc. C5aR antagonists
US8906938B2 (en) 2008-12-22 2014-12-09 Chemocentryx, Inc. C5aR antagonists
US10660897B2 (en) 2008-12-22 2020-05-26 Chemocentryx, Inc. C5aR antagonists
US9126939B2 (en) 2010-06-24 2015-09-08 Pingchen Fan C5AR antagonists
US9573897B2 (en) 2010-06-24 2017-02-21 Chemocentryx, Inc. C5AR antagonists
US10035768B2 (en) 2010-06-24 2018-07-31 Chemocentryx, Inc. C5aR antagonists
US9745268B2 (en) 2014-09-29 2017-08-29 Chemocentryx, Inc. Processes and intermediates in the preparation of C5aR antagonists
US10266492B2 (en) 2014-09-29 2019-04-23 Chemocentryx, Inc. Processes and intermediates in the preparation of C5aR antagonists
US10532982B2 (en) 2014-09-29 2020-01-14 Chemocentryx, Inc. Processes and intermediates in the preparation of C5aR antagonists
US11845729B2 (en) 2014-09-29 2023-12-19 Chemocentryx, Inc. Processes and intermediates in the preparation of C5aR antagonists
US11285138B2 (en) 2016-01-14 2022-03-29 Chemocentryx, Inc. Method of treating C3 glomerulopathy

Also Published As

Publication number Publication date
WO2008022060A2 (fr) 2008-02-21

Similar Documents

Publication Publication Date Title
WO2005074603A3 (fr) Utilisation d'aminobenzoxazoles comme agents therapeutiques
WO2008022060A3 (fr) composés organiques et leurs utilisations
WO2006023515A3 (fr) Nouveaux inhibiteurs thiazole de la fructose 1,6-bisphosphatase
EA200900136A1 (ru) Пирролопиримидины для фармацевтических композиций
WO2007140385A3 (fr) Nouveaux composés en tant que ligands des récepteurs des cannabinoïdes et utilisations de ceux-ci
WO2007143422A3 (fr) Composés de pyridyl amide substitués utilisés comme modulateurs du récepteur de l'histamine h3
WO2007136592A3 (fr) Compositions à base de quinolones substituées et leurs utilisations
WO2004035569A3 (fr) Nouveaux composes antibacteriens
WO2008080015A3 (fr) Composés et procédés pour la modulation des kinases, et indications correspondantes
WO2008057775A3 (fr) Composés d'amide hétérocyclique utiles comme inhibiteurs de kinase
WO2006094292A3 (fr) Nouveaux composes a base de thienopyridine et procedes d'utilisation correspondants
WO2005110410A3 (fr) Inhibiteurs de kinases en tant qu'agents therapeutiques
MY153971A (en) Sulfonamides as trpm8 modulators
WO2008011130A3 (fr) Composés amidés
WO2008062905A3 (fr) Composé hétéromonocyclique et ses utilisations
WO2009051244A1 (fr) Composé hétérocyclique
WO2005074642A3 (fr) Composes chimiques
WO2005097788A3 (fr) Sulfonamides et utilisations de ceux-ci
WO2008128639A8 (fr) Thiadiazolyloxyphénylamidines et leur utilisation comme fongicides
WO2007056159A3 (fr) Derives d'hydrazone et utilisations de ceux-ci
NO20082096L (no) Azaindol-2-karboksamidderivativer
WO2007059230A3 (fr) 1h-benzimidazole-4-carboxamides substitues efficaces en tant qu’inhibiteurs de parp
WO2009040952A1 (fr) Médicament renfermant un dérivé de benzophénone ou son sel
WO2008009924A3 (fr) Indoles utiles dans le traitement de l'inflammation
WO2008030795A3 (fr) Compositions et procédés d'inhibition de tyrosine kinases

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07814015

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07814015

Country of ref document: EP

Kind code of ref document: A2